$98.4M in CY2024 Part D spend11.1M claims · 4.5M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Cyclobenzaprine used for?
INDICATIONS AND USAGE Cyclobenzaprine hydrochloride tablets, USP are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal c....
Is there a generic for Cyclobenzaprine?
Yes. 36 ANDAs filed at FDA, 15 generic manufacturers currently shipping.
How much does my plan pay for Cyclobenzaprine?
Across 329 Part D plans, Cyclobenzaprine averages $0.018/unit (NADAC). Lowest available: $0.018/unit. Highest in distribution: $0.018/unit.
Is Cyclobenzaprine on the FDA shortage list?
No. Cyclobenzaprine is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.